Actively Recruiting

Phase Not Applicable
Age: 50Years - 77Years
All Genders
NCT06910956

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Led by Massachusetts General Hospital · Updated on 2026-05-11

1500

Participants Needed

1

Research Sites

110 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

H

Harvard Risk Management Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer screening CT participation at 6 months after the baseline outpatient visit? The intervention is an alert to the provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool. Intervention and non-intervention arms will be compared to determine if lung cancer screening CT participation increases. Individuals who are considered high-risk by the tool, but who do not meet the Medicare/USPSTF pack-year or quit-date lung screening eligibility criteria may be offered research lung screening CT.

CONDITIONS

Official Title

Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT

Who Can Participate

Age: 50Years - 77Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Scheduled outpatient appointment with participating provider
  • Age between 50 and 77 years
  • Current or former smoker, including those potentially eligible for lung screening based on Medicare guidelines
  • Recent posteroanterior chest radiograph within 2 years
Not Eligible

You will not qualify if you...

  • History or signs/symptoms of lung cancer
  • Chest CT scan within the last 2 years
  • Clinical indication for chest CT other than lung cancer screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

M

Michael T Lu, MD, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SCREENING

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here